C07F 9/5333
Arylalkane phosphine oxides or thioxides
Official title: {Arylalkane phosphine oxides or thioxides (C07F9/5329 takes precedence)}
C07F9/5333 (Arylalkane phosphine oxides or thioxides) appears on 36 US grants and 16 published applications in this corpus.
Search patents in C07F- Granted patents
- 36
- Published applications
- 16
- Assignees
- 23
- Inventors
- 124
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 3 |
| 2016 | 0 | 0 |
| 2017 | 3 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 2 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
| 2025 | 2 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Electron injection layer for an organic light-emitting diode (OLED)24 Feb 2026US 12,563,963 B2Novaled GmbH
- Heterocyclic compound and organic light-emitting device comprising same2 Sep 2025US 12,404,278 B2Lt Materials Co., Ltd.
- APOL1 inhibitors and methods of use1 Jul 2025US 12,344,610 B2Maze Therapeutics, Inc.
- APOL1 inhibitors and methods of use7 May 2024US 11,976,067 B2Maze Therapeutics, Inc.
- Phosphorus-containing compound and preparation and use thereof10 May 2022US 11,325,929 B2VivaVisionShanghaiLtd
- Apol1 inhibitors and methods of use11 Sep 2025US 2025/0282781 A1Maze Therapeutics, Inc.
- Apol1 inhibitors and methods of use5 Dec 2024US 2024/0400565 A1Maze Therapeutics, Inc.
- Apol1 inhibitors and methods of use24 Aug 2023US 2023/0265096 A1Maze Therapeutics, Inc.
- Substituted aryl compound11 May 2023US 2023/0142274 A1Jiangsu Simcere Pharmaceutical Co., Ltd.
- Heterocyclic compound and organic light-emitting device comprising same8 Sep 2022US 2022/0281884 A1Lt Materials Co., Ltd.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Retroviral protease inhibiting compounds44US 5,648,497 AAbbott Laboraotries · 1997
- Retroviral protease inhibiting compounds28US 5,256,677 AAbbott Laboratories · 1993
- Retroviral protease inhibiting compounds24US 5,151,438 AAbbott Laboratories · 1992